Vimarsana
Biggest News Aggregation in the World

Xmt 1536 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xmt 1536. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xmt 1536 Today - Breaking & Trending Today

Upifitamab Rilsodotin Fails to Meet ORR End Point in NaPi2b+ Platinum-Resistant Ovarian Cancer - Vimarsana News

Upifitamab Rilsodotin Fails to Meet ORR End Point in NaPi2b+ Platinum-Resistant Ovarian Cancer

The phase 1/2 UPLIFT trial evaluating the antibody-drug conjugate upifitamab rilsodotin in patients with platinum-resistant ovarian cancer failed to meet its primary end point of investigator-assessed overall response rate in the NaPi2b-positive population.